Epsilon Healthcare Limited (9TH0)
Market Closed
7 Aug, 20:00
XFRA 
€
0. 01
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
36,000 Volume
0 Eps
€ 0.01
Previous Close Want to track 9TH0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
9TH0 closed Friday higher at €0.01, an increase of 0% from Thursday's close, completing a monthly increase of 25% or €0. Over the past 12 months, 9TH0 stock lost -31.8182%.
9TH0 is not paying dividends to its shareholders.
The last earnings report, released on May 14, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on ASX (AUD).
9TH0 Chart
Epsilon Healthcare Limited (9TH0) FAQ
What is the stock price today?
The current price is €0.01.
On which exchange is it traded?
Epsilon Healthcare Limited is listed on XFRA.
What is its stock symbol?
The ticker symbol is 9TH0.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Epsilon Healthcare Limited ever had a stock split?
No, there has never been a stock split.
Epsilon Healthcare Limited Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Peter Giannopoulos CEO | XFRA Exchange | AU0000137598 ISIN |
| AU Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Epsilon Healthcare Limited is a prominent healthcare and pharmaceutical company with a primary operational focus in Australia and Canada. Initially started under the name THC Global Group Limited, the company underwent a name change in February 2021 to better reflect its broadening scope in healthcare and pharmaceuticals. Since its incorporation in 2016, Epsilon Healthcare has dedicated itself to being at the forefront of medicinal cannabis research, development, and distribution, along with providing a comprehensive range of hydroponics equipment, materials, and nutrients. Epsilon is headquartered in Sydney, Australia, from where it directs its operations and strategic expansion efforts.
Products and Services
- Manufacture and Distribution of Hydroponics Equipment, Materials, and Nutrients: Epsilon Healthcare Limited offers an extensive range of hydroponics supplies, from state-of-the-art equipment to essential materials and nutrients, catering to the diverse needs of hydroponic cultivation enthusiasts and professionals alike. These products are critical in enabling efficient and effective indoor cultivation of a variety of plants, including medicinal cannabis, by controlling environmental conditions and providing necessary nutrients.
- Medicinal Cannabis Development and Delivery: Epsilon specializes in the research, development, and distribution of medicinal cannabis products. Leveraging cutting-edge science and technology, the company focuses on creating high-quality medicinal cannabis products to meet the growing demand in legal markets in Australia, Canada, and potentially beyond. Their commitment to quality and therapeutic efficacy stands at the core of their medicinal cannabis offerings.
- Turnkey Cannabis Cultivation Solutions: Beyond individual products and services, Epsilon Healthcare Limited provides comprehensive, end-to-end cannabis cultivation solutions. These turnkey services are designed to assist clients from the planning stage through to cultivation and harvesting, encompassing facility design, setup, maintenance, and operational guidance. This holistic approach ensures that clients can efficiently set up and manage their cannabis cultivation operations with expert support at every step.
Contact Information
Address: 9 Castlereagh Street
Phone: 61 2 9299 8977
Website: https://epsilonhealthcare.com.au
